Objective: Left-ventricular function has been shown to be an important prognostic factor in estimating operative risk in cardiac surgery. As such, left-ventricular ejection fraction (LVEF) is included in the EuroSCORE. However, left-ventricular function is more comprehensively assessed by measures of both systolic and diastolic dysfunction. We hypothesised that end-diastolic dysfunction is an additional independent indicator for predicting outcome following coronary artery bypass grafting (CABG). Methods: We retrospectively assessed all patients undergoing isolated off-pump CABG between October 2000 and September 2004 by two surgeons. Left-ventricular end-diastolic pressure (LVEDP), measured during cardiac catheterisation, was used as a measure of left-ventricular diastolic dysfunction. Logistic regression was used to assess the association between LVEDP (a continuous and dichotomous variable) and mortality, while adjusting for EuroSCORE. Results: A total of 925 patients with complete LVEDP data were identified and stratified as follows: group 1 (LVEF >30% and LVEDP <20 mmHg), group 2 (LVEF <30% and LVEDP <20 mmHg), group 3 (LVEF >30% and LVEDP >20 mmHg) and group 4 (LVEF <30% and LVEDP >20 mmHg). Mortality increased progressively from group 2 (1.9%, odds ratio (OR) 1.22, RR 1.21, p 0.58) to group 3 (5.6%, OR 3.81, RR 3.66, p 0.07) and was highest in group 4 (7.4%, OR 5.18, RR 4.87, p 0.08). Receiver operating characteristic (ROC) curve c-characteristic improved from 0.7 to 0.78 when EuroSCORE was combined with LVEDP, identifying LVEDP as an independent predictor of mortality after adjusting for EuroSCORE. Logistic equation: odds of death = exp(À6.3283 + [EuroSCORE Â 0.1813] + [EDP Â 0.0954]). Conclusions: LVEDP as a marker of diastolic dysfunction seems an important variable in predicting patient-specific risk and should be considered for incorporation in future risk models. #
Introduction
Preoperative risk stratification of mortality in cardiac surgery has become increasingly important. Risk-stratified scoring schemes such as EuroSCORE [1] , Parsonnet score [2] and the New England score [3] are extensively used in current practice. However, there is increasing evidence that outcomes following low-risk elective surgery in specialist cardiac units routinely outperform the predicted risk [4] , whilst risk is often underestimated in complex cases, leading to the conviction that the accuracy of scoring systems could potentially be improved by the inclusion of more sensitive parameters. Cardiac-specific factors known to be of prognostic value include recent infarction, unstable angina and, critically, left-ventricular dysfunction [1] . In the literature, impaired left-ventricular function has clearly been associated with difficulty in weaning from cardiopulmonary bypass [5] , haemodynamic instability in the perioperative period [6] and increased in-hospital mortality [7, 8] . This is especially pertinent in view of the current American College of Cardiology/American Heart Association (ACC/AHA) guidelines, which acknowledge that patients with left-ventricular dysfunction are precisely the population that stand to gain the most from surgical revascularisation. To date, all riskscoring systems have focussed on the impact of systolic dysfunction on postoperative outcomes. However, a more global appraisal of ventricular function requires consideration of both the systolic and diastolic components [9, 10] .
This hypothesis forms the basis of this study, which specifically seeks to identify the value of left-ventricular end-diastolic pressure (LVEDP) as a predictor of mortality risk, independent of left-ventricular systolic dysfunction, as already used within the EuroSCORE system.
Patients and methods

Patient selection
Our institutional database was used to retrospectively identify patients undergoing isolated surgical revascularisation with a record of preoperative LVEDP. Recording of LVEDP was found to be unique to the practice of two surgeons, both of whom predominantly used off-pump techniques for revascularisation whenever possible. To homogenise the population, therefore, the minority of patients who had undergone revascularisation on cardiopulmonary bypass were excluded from analysis. Poor systolic function was determined by left-ventricular ejection fraction (LVEF) <30%, either by echocardiography or by angiographic estimation. Poor diastolic function was determined as LVEDP >20 mmHg and measured during cardiac catheterisation (see below). Patients were stratified according to the permutations of systolic and diastolic function. For the purpose of this study, systolic function was considered to be preserved if the estimated ejection fraction was greater than 30%. Similarly, preserved diastolic function was assumed if LVEDP was below 20 mmHg. The four groups included: group 1 -preserved systolic function, preserved diastolic function group 2 -poor systolic function, preserved diastolic function group 3 -preserved systolic function, poor diastolic function group 4 -poor systolic function, poor diastolic function
Measurement of LVEDP
LVEDP was measured at the time of elective left-heart catheterisation prior to referral for surgery. To facilitate inter-patient standardisation of the recording, LVEDP was routinely measured immediately prior to ventricular contraction with the tip of the catheter at the level of the right atrium with the patient in full expiration. Critical EDP measurements were taken prior to the injection of any contrast to eliminate the effect of contrast-induced impairment of ventricular function. Timing was verified angiographically and confirmed by electrocardiogram (ECG) as follows. The Z point on the left-ventricular pressure trace identifies the turning point between passive ventricular filling and isovolumetric contraction. LVEDP was recorded at the Z point, which immediately precedes the R wave on the ECG, approximately 50 ms after the Q wave. An average of six measurements was taken to ensure reproducibility.
Data collection and statistical analysis
Preoperative demographic and pathophysiological parameters were recorded on the institutional database at the time of hospital admission. Outcome data were recorded at the time of discharge. The endpoints nominated to assess outcome were in-hospital mortality and length of intensive therapy unit (ITU) stay. Chi-square, Fisher's exact, and Wilcoxon rank-sum tests were used as appropriate. A p-value <0.05 was considered significant. Additive and logistic EuroSCORE was used preoperatively to determine mortality risk. Logistic regression analysis was used to identify the value of LVEDP as an independent predictor of mortality over and above EuroSCORE.
Operative technique
All patients included in this study underwent isolated offpump coronary artery bypass grafting (OPCAB), through a standard median sternotomy, using the Medtronic Octopus stabiliser. Intracoronary shunts were used to facilitate visualisation and maintain distal perfusion. The left internal mammary artery was used wherever possible to bypass left anterior descending artery stenoses. Subsequent conduit selection (right internal mammary, radial artery and saphenous vein) was determined by availability, nature of coronary targets and surgeon's preference. Aspirin and clopidogrel were prescribed routinely from the first postoperative day to ensure graft patency. Patients with previously noted left-ventricular dysfunction were recommenced on anti-failure therapy (including angiotensinconverting enzyme (ACE) inhibitors) in the early postoperative period.
Results
A total of 925 patients were identified within the database as fulfilling the eligibility criteria for this analysis. Table 1 shows the distribution of risk factors and outcomes in the four subpopulations defined by systolic and diastolic function.
Group 1 comprised 790 patients, group 2 (isolated systolic dysfunction) and group 3 (isolated diastolic dysfunction) held 54 patients each and group 4 (combined systolic and diastolic dysfunction) contained 27 patients. The average age was 64.9, with no significant difference in average age across the four groups ( p 0.27-0.86). When compared with group 1, group 2 patients were statistically more likely to have had previous myocardial infarction (83.3% in group 2 vs 36.7% in group 1, p < 0.01) and extracardiac arteriopathy (24.1% in group 2 vs 11.9% in group 1, p < 0.01). Group 3 patients were likely to have diabetes (37.0% in group 3 vs 21.3% in group 1, p < 0.01), extracardiac arteriopathy (25.9% in group 3 vs 11.9% in group 1, p < 0.01) and preoperative renal dysfunction (9.3% in group 3 vs 2.8% in group 1, p 0.02). Group 4 patients were more likely to have had previous myocardial infarction (70.4% vs 36.7% in group 1, p < 0.01), non-elective surgery (33.3% vs 12.9% in group 1, p < 0.01) and triple-vessel disease (92.6% vs 74.2% in group 1, p = 0.04). Fig. 1 shows the mortality rate in each of the four groups. As expected, mortality is highest in group 4 patients (7.4%) with combined systolic and diastolic dysfunction ( Table 2) . Not surprisingly, patients with systolic dysfunction (group 2) have increased perioperative mortality (1.9%, p 0.58, OR 1.22, RR 1.22, 95% CI). However, group 3 patients with evidence of diastolic dysfunction in the presence of apparently preserved systolic function have an even higher mortality (5.6%) with increased OR when compared with group 1 ( p 0.07, OR 3.81, RR 3.66). Comparing group 2 against group 4 allowed us to consider the impact of diastolic dysfunction over and above impaired LV systolic function -this comparison indicates that the increased mortality in group 4 (7.9%) is not statistically significant when compared with group 2 (1.9%), p = 0.26. We also examined the impact of increasing LVEDP on mortality. Using the additive EuroSCORE, all 925 patients were stratified by LVEDP into four groups: LVEDP 5-10 mmHg, 10-15 mmHg, 15-20 mmHg and >20 mmHg. The relationship between additive EuroSCORE and mortality risk for each group is displayed graphically in Fig. 2 . Mortality rises with increasing EuroSCORE although the latter overestimates this risk, especially at scores above 5. The further stratification by Fig. 1 . Effect of augmented LVEDP on EuroSCORE -mortality relationship (barchart). Fig. 2 . Effect of augmented LVEDP on EuroSCORE -mortality relationship (graph). Fig. 3 . ROC curve depicting additive value of LVEDP for mortality prediction.
LVEDP (as a measure of diastolic dysfunction) augments this effect with a leftward shift of the curve that actually approaches predicted mortality, especially with an LVEDP >20 mmHg. In an effort to quantify the potential (additive) predictive value of LVEDP, a receiver operating characteristic (ROC) curve was constructed (Fig. 3) . 
Discussion
Risk stratification in cardiac surgery continues to evolve as operative techniques improve and patient demographics change. Development of an accurate and current riskprediction model remains an ongoing process. The many scoring systems proposed to date have all been developed from retrospective analysis of observed outcomes in cardiac surgical populations. There is, therefore, an unavoidable bias towards the patient population studied and local surgical practice. Early experience with scoring systems such as the Parsonnet score confirmed that there was significant variability in the predictive value between surgical centres, geographical locations and even individual surgeons. Further research based on European cardiac surgical populations led to the development of EuroSCORE. The additive EuroSCORE system allows for rapid bedside risk evaluation and has therefore proven very popular with clinicians. Yet, the ideal remains to develop a highly patientspecific risk model that will allow accurate risk estimation based on easily obtainable objective parameters, but which still retains sufficient flexibility to be used across a wide patient (and surgeon) population. The existence of multiple risk-scoring systems (New England, Apache III, Cleveland, etc.) reflects the difficulty that has been experienced in achieving this goal. One particular challenge is that most scoring systems lose sensitivity at the risk extremes of the cardiac surgical spectrum, where data are less in abundance. Increased specificity and sensitivity would intuitively be associated with the incorporation of more parameters. However, inclusion of several variables, each with minor predictive value, potentially achieves only a small increase in sensitivity at the cost of generating a cumbersome risk tool that is difficult to use. The key therefore is to choose the physiological parameters of greatest value. Ventricular function has been proven to be a valuable predictive parameter. Systolic function may be evaluated in several ways, including estimation of ejection fraction, regional wall motion scoring and even visual inspection of the heart during surgery. In addition, and based on the findings of this study, we would propose that an estimate of diastolic ventricular function merits further investigation, prior to potential inclusion in future risk-stratification models. Diastolic ventricular function reflects a loss of compliance of the myocardium, which has traditionally been thought to be due to the ventricular remodelling process triggered by acute or chronic ischaemia. More recent literature has suggested that markers of diastolic dysfunction appear very early on in the pathogenesis of myocardial ischaemia and may even precede the onset of systolic dysfunction [11] . Loss of ventricular compliance increases LVEDP and increases left-ventricular end-diastolic volumes (LVEDVs) and, consequently, has the ultimate effect of reducing cardiac output as well as threatening subendocardial perfusion due to increased ventricular wall tension. This loss of optimal cardiac output and impedance to coronary blood flow has the potential to create significant haemodynamic instability in the critical perioperative period, especially in patients with concomitant systolic failure. This study has explored the value of one marker of diastolic dysfunction, namely LVEDP. One inherent disadvantage in using LVEDP is that it necessitates an invasive procedure and potentially suffers from significant operator variability. Left-ventricular enddiastolic dimension may prove to be a reasonable alternative marker of diastolic dysfunction, because it may be evaluated on transthoracic echocardiography. An even more sophisticated approach may be to assess end-diastolic ventricular wall stress using echocardiographic techniques. Examination of such techniques is beyond the scope of this article. However, it is to be noted that diastology (the study of cardiac diastole and its components) is becoming increasingly relevant in current cardiac surgical practice [12] for a number of reasons. First, the patient population is changing to feature an increased incidence of diabetic patients in whom autonomic neuropathy creates a situation of subclinical chronic ischaemia, resulting in late presentation with advanced myocardial injury. An ageing population with increased incidence of diffuse, complex multivessel disease or previous coronary artery bypass grafting (CABG) also increases the likelihood of presentations where ventricular remodelling has become advanced [13] . The practice of antifailure surgery combining CABG with operative strategies to remodel the non-compliant ventricle is also on the rise, and these patients represent a specific population where diastolic dysfunction potentially has significant impact on mortality outcomes. For these reasons, we would propose Table 2 Observed mortality stratified according to systolic and diastolic function.
Group 1 (n = 790) Group 2 (n = 54) Group 3 (n = 54) Group 4 (n = 27) LVEF >30% <30% >30% <30% LVEDP (mmHg) <20 <20 >20 >20
In hospital mortality (%) that diastolic dysfunction as represented by elevated LVEDP has predictive value for mortality following surgical revascularisation and has the potential to improve the predictive accuracy of the additive EuroSCORE. The overall incidence of mortality in our study is low, and accordingly, the mortality differences in diastolic dysfunction groups 3 and 4 are of borderline statistical significance. However, Fig. 2 indicates that diastolic dysfunction increases the accuracy of EuroSCORE. We therefore conclude that diastolic dysfunction is an important predictor of post-CABG mortality in an increasingly complex surgical population, and merits further investigation prior to possible inclusion in newer risk-stratification systems.
